Amino acids 484 and 494 of SARS-CoV-2 spike are hotspots of immune evasion affecting antibody but not ACE2 binding

Marta Alenquer; Filipe Ferreira; Diana Lousa; Mariana Valerio; Monica Medina-Lopes; Marie-Louise Bergman; Juliana Goncalves; Jocelyne Demengeot; Ricardo B. Leite; Jingtao Lilue; Zemin Ning; Carlos Penha-Goncalves; Helena Soares; Claudio Soares; Maria Joao Amorim.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-441007

Documentos relacionados

  1. Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.
  2. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
  3. Generation of SARS-CoV-2 spike receptor binding domain mutants and functional screening for immune evaders using a novel lentivirus-based system.
  4. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
  5. Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain.
  6. Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.
  7. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
  8. Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation.
  9. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
  10. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations.